David Friedmann is an accomplished professional in regulatory affairs and business development, currently serving as Director of Regulatory Affairs Business Excellence - Aesthetics at AbbVie since May 2019. With a strong background in project management and strategy, David previously held roles including Associate Director for Regulatory Portfolio Management and Project Management at AbbVie. Prior experience includes consulting at Slalom Consulting, where David provided strategic insights to Fortune 500 clients, and serving as Business Development Manager at Cincinnati Children's Hospital Medical Center, focusing on technology licensing and partnership development. David's education includes a Ph.D. in Molecular Genetics, Biochemistry, and Microbiology from the University of Cincinnati College of Medicine and a B.A. in Microbiology from Miami University.
This person is not in any teams
This person is not in any offices